Lymphangioleiomyomatosis: a rare cause of breathlessness by Vinodh, B. N. et al.
RADIOLOGY FORUM
Lymphangioleiomyomatosis : A Rare Cause of
Breathlessness
B.N. Vinodh, S.K. Sharma, S. Mukhopadhyay1 and S. Datta Gupta2
Departments of Medicine, Radiodiagnosis1 and Pathology2, All India Institute of Medical Sciences,
Ansari Nagar, New Delhi, India
[Indian J Chest Dis Allied Sci 2004; 46 : 205-208]
[Received: November 24, 2003; accepted after revision: April 7, 2004]
Correspondence and reprints request: Dr S.K. Sharma, Professor and Head, Department of Medicine, Chief
Division of Pulmonology and Critical Care Medicine, All India Institute of Medical Sciences, Ansari Nagar, New
Delhi-110 029, India; Tele.: 91-11-26594415; Telefax: 91-11-26588641; E-mail: <sksharma@aiims.ac.in>.
CLINICAL SUMMARY
A 24-year-old female presented with com-
plaints of cough with scanty expectoration,
breathlessness on exertion and  chest pain for
the last three years. These symptoms had
appeared during the 12th week of her third
pregnancy. She was given anti-tuberculosis
treatment at another hospital for nine months
without any improvement in symptoms. Four
years ago she had been diagnosed to have
leprosy of borderline variety for which she had
received treatment. On examination, she was
tachypnoeic with a respiratory rate of 33 breaths
per minute. She had clubbing and small,
discrete and firm lymph nodes in the anterior
cervical region. Chest examination revealed
wheezing with bibasilar end-inspiratory
crepitations.
INVESTIGATIONS
A plain chest radiograph revealed  extensive
small cystic lesions involving the entire lung
fields on both the sides, large cystic lesions in
the right upper lobe, mildly increased lung
volume and obliteration of the right costo-
phrenic angle with a small area of calcification
in the right lower lobe (Figure 1). Arterial blood
gas analysis while breathing room air revealed:
pH of 7.35, PaCO2 of 27.8 mmHg, PaO2 of 93.6
mmHg, HCO3 of 17.1 meq/l and oxygen
saturation of 96.2 per cent. Spirometry revealed
FVC 30%, FEV1 35% and PEFR 75% of the
predicted value. FEV1/FVC 118% with diffusion
capacity of the lung for carbon monoxide
(DLCO) (steady state method) 21.8% of the
predicted value.
Figure 1. Chest radiograph (PA view) showing the
extensive small cystic lesions involving the entire
lung fields on both sides.
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The high resolution computerised (HRCT)
scan of the chest revealed extensive varied sized
thin-walled cysts distributed throughout both
the lung fields with the cyst size ranging from
one millimeter to 3.5 centimeter in diameter. No
lung zone was spared. Most of the cysts had
perceptible thin wall with the majority of them
having round or oval shape and some having
irregular outline. The lung parenchyma between
the cysts was normal. The main and left
pulmonary arteries were enlarged. Few small
pre-tracheal and pre-carinal lymph nodes were
seen. Mild pleural thickening was observed in
the left lower zone (Figure 2).
Figure 2.  High resolution computerised (HRCT)
scan of the chest through upper lobes showing the
thin-walled cysts of varying sizes (1 mm to 3.5 cm).
Figure 3. Higher power showing smooth muscle
bundles (arrow) around vascular spaces with some
lymphocytes (Masson’s Trichrome x 40).
Video-assisted thoracoscopy of the right lung
revealed a shrunken fibrotic lung with multiple
cysts all over the lung fields. A biopsy taken
from the right lung showed alveoli with
thickened walls with inflammation and
muscularisation around slit like spaces. Special
staining with Masson’s trichrome stain showed
smooth muscle bundles around vascular spaces
with some lymphocytes (Figure 3). However,
immunofluorescence study with HMB-45 was
negative. Based on these features, a diagnosis of
lymphangioleiomyomatosis (LAM) was made
and the patient was started on monthly
medroxyprogesterone 450 mg i.m. The patient
was followed up for four years. She had one
episode of spontaneous pneumothorax, which
was managed with underwater seal drainage.
Her breathlessness increased gradually and the
patient became breathless even at rest by the
end of the fourth year. A repeat lung function
study and HRCT scan of the chest during the
third year of follow-up did not show any
change from the earlier findings. She developed
features of chronic cor-pulmonale by the end of
four years. A repeat arterial blood gas analysis
with the patient breathing room air revealed:
pH of 7.394, PaCO2 of 35.0 mmHg, PaO2 of 58.4
mmHg, HCO3
- of 17.1 meq/l and oxygen
saturation of 89.5 percent. Patient was put on
continuous domiciliary oxygen therapy at four
litre per minute and is being followed up.
DIAGNOSIS
Lymphangioleiomyomatosis (LAM)
DISCUSSION
Lymphangioleiomyomatosis (LAM) is a rare
disease of unknown cause, first described in
19371,2. It predominantly occurs in women of
reproductive age group. It occurs frequently in
association with  tuberous sclerosis (TSC) and is
characterised by alveolar smooth muscle
proliferation and cystic destruction of the
normal lung parenchyma. To date more than
445 cases have been reported3. The prevalence of
LAM in TSC population is estimated to be
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between one to three percent3. Except for
occasional case reports no epidemiological
reports are available from the Indian
subcontinent4.
LAM commonly presents with dyspnoea
(often due to spontaneous pneumothorax and
pleural effusion), chronic cough, haemoptysis,
wheeze, chest pain and ascites. About 50% of the
patients present with recurrent pneumothorax.
Our case did not have pneumothorax at the time
of presentation. However during the follow-up
period, she developed one episode of
pneumothorax that was managed with under-
water seal drain. The pulmonary function tests
(PFT) in LAM show wide range of patterns from
normal to obstructive  through a mixed picture
to restrictive with the obstructive pattern being
common. The PFT in our patient revealed a
restrictive pattern. It also revealed a markedly
decreased DLCO which is the most frequent
abnormality seen in LAM. Our case developed
type 1 respiratory failure and cor-pulmonale at
the end of four years. These along with cyanosis
are the complications seen at the end stages of
LAM.
The chest radiographic features of extensive
small cystic lesions involving the entire lung
fields on both the sides with increased lung
volumes as seen in this case are the frequent
findings described in LAM. However in the
initial stages, chest radiograph may  be normal.
In such cases HRCT scan may show the abnor-
malities, as it is a  more sensitive indicator of
early disease5. The presence of  numerous thin
walled cysts ranging from one millimeter to
several centimeters in size  involving the lungs
diffusely is characteristic. These characteristic
features on HRCT scan can obviate the need of
a lung biopsy to establish the diagnosis.
Langerhans cell histiocytosis, idiopathic
pulmonary fibrosis and emphysema were the
differential diagnosis in our case. However, the
characteristic type  and distribution of lesions
helped in differentiating LAM from these
entities.
Light  microscopy findings of the lungs are
characterised by diffuse interstitial proliferation
of bundles of  “immature” smooth muscle cells.
These cells have a benign  appearance and
immunohistochemistry shows smooth muscle
cells. These cells have a benign appearance and
immunohistochemistry shows smooth muscle
actin and melanoma associated antigens. These
antigens are called HMB-45 antigens and are
useful for diagnosis of LAM  because LAM is
the unique smooth muscle cell proliferation in
the lung that expresses such antigen5. However,
in our case this was negative.
Management of LAM is mainly symptomatic
and includes the symptomatic treatment  of
wheezing, pneumothoraces and pleural
effusions. It is not uncommon for these patients
to be treated as tuberculosis, as was seen in our
case, because of the lack of awareness and
facilities of a diagnostic lung biopsy in India4.
Since LAM is usually seen in women of
reproductive age group hormonal factors are
thought to be involved in its pathogenesis.
Hence hormonal manipulations, like
progesterone, oophorectomy, tamoxifen and
gonadotrophin releasing hormone agonists
have been used to prevent the progression of the
lung disease but with mixed results. A meta-
analysis of 30 cases, which included eight
patients treated with progesterone alone, has
demonstrated a success rate (improvement or
stabilization) of 50% with progesterone use6.
Hence, progesterone therapy is considered as
the first-line therapy for LAM. The presence of
chylous effusion or ascites is correlated with the
responsiveness to medroxyprogesterone6.
Unfortunately our patient continued to
deteriorate despite being on medroxypro-
gesterone. Lung transplantation is the best
therapeutic option in these cases in the event of
failure of medical treatment and in end stage
disease7. However, recurrence of LAM has been
described in the allograft also8,9. The overall
long-term prognosis of LAM is poor. Most of the
patients deteriorate relentlessly after the
appearance of symptoms and succumb to death
due to respiratory failure by the end of 10 years.
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